Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Placental extract for ovarian reserve in women with endometriosis
IRCT20191123045476N6Phase 3Recruiting
- Sponsor
- Iran University of Medical Sciences
- Start
- Jul 2026
- Modality
- Device-based Delivery → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3, double-blind trial of LAENNEC in endometriosis (2 arms), sponsored by Iran University of Medical Sciences. Primary endpoint: Change in anti-Mullerian hormone levels. Started Jul 2026; status: recruiting.
02
Drugs
LAENNEC
03
Conditions
endometriosis
Beyond the preview
Go deeper on IRCT20191123045476N6.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20191123045476N6.